Literature DB >> 9685161

V(D)J recombinase induction in splenic B lymphocytes is inhibited by antigen-receptor signalling.

M Hertz1, V Kouskoff, T Nakamura, D Nemazee.   

Abstract

In lymphocytes, DNA recombinations that generate the antigen-receptor genes can sometimes be reinduced in receptor-bearing cells in a process called receptor editing, which modifies the specificity of the receptor for antigen. In immature B lymphocytes, B-cell antigen receptor (BCR) signalling stimulates immune tolerance by receptor editing. More mature splenic B cells can also be induced to undergo V(D)J recombination, which generates diversity in the immune system, either by immunization with foreign proteins or by stimulation in vitro with interleukin-4 and lipopolysaccharides. Here we show that immune tolerance is unlikely to induce V(D)J recombination in mature B cells, because BCR ligation actively inhibits V(D)J recombination induced by interleukin-4 and lipopolysaccharide. Furthermore, immunization of immunoglobulin transgenic mice with ligands of varying avidities for the BCR showed that low-avidity antigen could induce strong V(D)J recombination, whereas non-binding or high-avidity ligands could not. These data suggest that V(D)J recombination induced during the immune response modifies the antigen receptors of B cells with weak, but not strong, reactivity to antigen, potentially rescuing cells with improved receptor affinity and promoting their contribution to the immune response. Thus BCR signalling regulates V(D)J recombination in both tolerance and immunity, but in strikingly different ways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685161      PMCID: PMC4523147          DOI: 10.1038/28419

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  23 in total

1.  Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection.

Authors:  D Melamed; R J Benschop; J C Cambier; D Nemazee
Journal:  Cell       Date:  1998-01-23       Impact factor: 41.582

2.  V(D)J recombinase activity in a subset of germinal center B lymphocytes.

Authors:  S Han; S R Dillon; B Zheng; M Shimoda; M S Schlissel; G Kelsoe
Journal:  Science       Date:  1997-10-10       Impact factor: 47.728

3.  BCR ligation induces receptor editing in IgM+IgD- bone marrow B cells in vitro.

Authors:  M Hertz; D Nemazee
Journal:  Immunity       Date:  1997-04       Impact factor: 31.745

Review 4.  Positive selection of thymocytes.

Authors:  P J Fink; M J Bevan
Journal:  Adv Immunol       Date:  1995       Impact factor: 3.543

Review 5.  Positive selection of thymocytes.

Authors:  S C Jameson; K A Hogquist; M J Bevan
Journal:  Annu Rev Immunol       Date:  1995       Impact factor: 28.527

6.  Antigen-induced B-cell death and elimination during germinal-centre immune responses.

Authors:  K M Shokat; C C Goodnow
Journal:  Nature       Date:  1995-05-25       Impact factor: 49.962

7.  Characterization of B cells expressing recombination activating genes in germinal centers of immunized mouse lymph nodes.

Authors:  M Hikida; M Mori; T Kawabata; T Takai; H Ohmori
Journal:  J Immunol       Date:  1997-03-15       Impact factor: 5.422

8.  Editing disease-associated autoantibodies.

Authors:  C Chen; E L Prak; M Weigert
Journal:  Immunity       Date:  1997-01       Impact factor: 31.745

9.  Neoteny in lymphocytes: Rag1 and Rag2 expression in germinal center B cells.

Authors:  S Han; B Zheng; D G Schatz; E Spanopoulou; G Kelsoe
Journal:  Science       Date:  1996-12-20       Impact factor: 47.728

10.  Activation of phosphatidylinositol-3' kinase by Src-family kinase SH3 binding to the p85 subunit.

Authors:  C M Pleiman; W M Hertz; J C Cambier
Journal:  Science       Date:  1994-03-18       Impact factor: 47.728

View more
  35 in total

Review 1.  Receptor selection in B and T lymphocytes.

Authors:  D Nemazee
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  Maintenance and loss of self-tolerance in B cells.

Authors:  A Iglesias
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 3.  Somatic hypermutation in human B cell subsets.

Authors:  N S Longo; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  2001-12

Review 4.  Studies of the humoral immune response.

Authors:  G Kelsoe
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

5.  Differential accessibility at the kappa chain locus plays a role in allelic exclusion.

Authors:  Maya Goldmit; Mark Schlissel; Howard Cedar; Yehudit Bergman
Journal:  EMBO J       Date:  2002-10-01       Impact factor: 11.598

6.  Antibody repertoire development in fetal and neonatal piglets. XXII. λ Rearrangement precedes κ rearrangement during B-cell lymphogenesis in swine.

Authors:  Xiuzhu Sun; Nancy Wertz; Kelly Lager; Marek Sinkora; Katerina Stepanova; Gregory Tobin; John E Butler
Journal:  Immunology       Date:  2012-10       Impact factor: 7.397

7.  Light chain inclusion permits terminal B cell differentiation and does not necessarily result in autoreactivity.

Authors:  C Sirac; C Carrion; S Duchez; I Comte; M Cogné
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-08       Impact factor: 11.205

8.  Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis.

Authors:  C Faber; H Morbach; S K Singh; H J Girschick
Journal:  Ann Rheum Dis       Date:  2006-02-27       Impact factor: 19.103

9.  Spontaneous autoimmunity in mice that carry an IghV partial transgene: a required arginine in VHCDR3.

Authors:  A Guth; T Detanico; D Smith; K S K Tung; C Bonorino; L J Wysocki
Journal:  Lupus       Date:  2009-04       Impact factor: 2.911

10.  Insights into the regulation of immunoglobulin light chain gene rearrangements via analysis of the kappa light chain locus in lambda myeloma.

Authors:  Vittorio Perfetti; Maurizio C Vignarelli; Giovanni Palladini; Valentina Navazza; Claudia Giachino; Giampaolo Merlini
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.